<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HCB5AEA9879CB4FF38B49BE4AF73137B1" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 1922 IH: Ensuring Access to Essential Drugs Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-03-06</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1922</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250306">March 6, 2025</action-date><action-desc><sponsor name-id="G000597">Mr. Garbarino</sponsor> (for himself, <cosponsor name-id="H001086">Mrs. Harshbarger</cosponsor>, and <cosponsor name-id="S001201">Mr. Suozzi</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.</official-title></form><legis-body id="H2B74416D87FA4D458B4A9A704DCD1980" style="OLC"><section id="H6AA59D6EB55E4FA58845E1841C500DA5" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Ensuring Access to Essential Drugs Act</short-title></quote>. </text></section><section id="HF44ED81632244FFE9CFE890221CF1560" section-type="subsequent-section"><enum>2.</enum><header>Exempting certain drugs from the part D manufacturer discount program under the Medicare program</header><text display-inline="no-display-inline">Section 1860D–14C(g)(2) of the Social Security Act (42 U.S.C. 1395w–114c(g)(2)) is amended—</text><paragraph id="H34F8722937EA416FA1583E0753E38CF7"><enum>(1)</enum><text>in subparagraph (A), by striking <quote>and</quote> at the end;</text></paragraph><paragraph id="HCB71D78DC1BC4B9FACCFDE57732ED5F9"><enum>(2)</enum><text>in subparagraph (B), by striking the period and inserting <quote>; and</quote>; and</text></paragraph><paragraph id="H6156D55C15E846678F92EF7CB61C1B0C"><enum>(3)</enum><text>by adding at the end the following new subparagraph:</text><quoted-block style="OLC" id="HB7F6E6E6EA084A6EA3EAFE820FD0011B" display-inline="no-display-inline"><subparagraph id="HE96A857BEAB74BB6B25CDBA66717B84E"><enum>(C)</enum><text display-inline="yes-display-inline">does not include an orally administered drug—</text><clause id="H684BDA3D5D3543E5B6180DA63EAEAA84"><enum>(i)</enum><text display-inline="yes-display-inline">for which a new drug application was approved under section 505 of the Federal Food, Drug, and Cosmetic Act; and</text></clause><clause id="H7A3BD2A6970E48708405D610110CAE25"><enum>(ii)</enum><text display-inline="yes-display-inline">that has been granted a narrow exception permitting reclassification as a noninnovator multiple source drug under the Medicaid drug rebate program by the Centers for Medicare &amp; Medicaid Services.</text></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section></legis-body></bill> 

